Qure.ai has secured $65 million in funding to invest in foundational AI models and acquire complementary startups in medical technology, as well as expand in the US and other markets. Korean firm Mediwhale has raised $12 million to seek US FDA approval for its AI-based Reti-CVD solution. Huawei has launched a new AI-powered medical imaging solution that promises to shorten disease diagnosis time by 40%. Korean pharmaceutical company GI Innovation is using AI for new drug discovery, while MediBuddy in India is incorporating Philips’ predictive heart AI into its mobile health application to assess key biomarkers for heart health.
Source link
Qure.ai pursuing large AI with $65M Series D funding and more briefs
